Clinical Trial Update: Study of the Safety, Pharmacokinetics and Efficacy of HPN-100, in Pediatric Subjects With Urea Cycle Disorders (UCDs) [Phase 3]

View source ↗

Summary

Phase 3 study of HPN-100 in pediatric patients with urea cycle disorders has completed and results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urea Cycle Disorders

Drugs mentioned

• HPN-100

Snippet

Sponsor: Amgen | Conditions: Urea Cycle Disorders | Phase 3 | Status: COMPLETED | Results posted: 2015-05-28